<DOC>
	<DOCNO>NCT00523289</DOCNO>
	<brief_summary>The purpose study determine bupivacaine ( 75 % levobupivacaine plus 25 % racemic bupivacaine ) vasoconstrictor effective safety ropivacaine brachial plexus block orthopedic surgery .</brief_summary>
	<brief_title>Cardiovascular Safety Research : Bupivacaine With Vasoconstrictor Versus Ropivacaine Brachial Plexus Block</brief_title>
	<detailed_description>The intoxication Bupivacaine consider life threaten . Currently safety local anesthetic substitution bupivacaine ropivacaine , however Brasil bupivacaine mixture 75 % levobupivacaine plus 25 % racemic bupivacaine . The research design : Patients involve : 48 ; age : 18 40 year old ; sex ; ASA I II . Surgery : elective upper extremity orthopedic surgery . Anesthesia technique : brachial plexus block . Primary endpoint : cardiovascular safety ; analysis continuous Holter . Secondary endpoint : anesthetic analgesic efficacy .</detailed_description>
	<mesh_term>Hand Injuries</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Patients involve : 48 ; ASA I II ; Surgery : elective upper extremity orthopedic surgery . Contraindications anesthesia technique and/or local anesthetic ; Participation different trial last two month ; Antiretroviral user ; Obesity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Ropivacaine</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Upper Extremity</keyword>
	<keyword>Local anesthetic</keyword>
</DOC>